Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$392,144
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-21 Heller Frances K Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-06-21 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-05-11 Hughes Thomas E. President and CEO Option exercise +18,928 $0.75 $14K 83,088
2017-05-11 Hughes Thomas E. President and CEO Option exercise +6,210 $0.75 $5K 89,298
2017-05-11 Hughes Thomas E. President and CEO Option exercise +68,073 $0.82 $56K 157,371
2017-05-11 Hughes Thomas E. President and CEO Option exercise · Stock Option (Right to Buy −18,928 0
2017-05-11 Hughes Thomas E. President and CEO Option exercise · Stock Option (Right to Buy) −6,210 0
2017-05-11 Hughes Thomas E. President and CEO Option exercise · Stock Option (Right to Buy) −68,073 0
2017-05-11 KIM DENNIS D Chief Medical Officer Purchase +9,800 $4.40 $43K 11,443
2017-05-10 KIM DENNIS D Chief Medical Officer Purchase +200 $4.40 $880 1,643
2017-02-13 Booth Bruce Director Grant or award · Stock Option (Right to Buy) +12,003 12,003
2017-02-13 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +13,289 13,289
2017-02-13 Daniel Thomas O Director Grant or award +10,765 $4.18 $45K 10,765
2017-02-13 McDonough Cameron Geoffrey Director Grant or award · Stock Option (Right to Buy) +13,718 13,718
2017-02-13 Barrett Peter Director Grant or award · Stock Option (Right to Buy) +24,864 24,864
2017-02-13 LAMATTINA JOHN L Director Grant or award +11,363 $4.18 $47K 11,363
2017-01-27 Hughes Thomas E. President and CEO Grant or award · Stock Option (Right to Buy) +319,000 319,000
2017-01-27 Allen Patricia L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +88,000 88,000
2017-01-27 KIM DENNIS D Chief Medical Officer Grant or award · Stock Option (Right to Buy) +88,000 88,000
2016-12-19 Heller Frances K Director Purchase +10,000 $3.23 $32K 30,000

Page 10 of 15 · 296 trades